Abiopharma

News list

Elliott Jeffrey Thomas 🟡 adjusted position in 0 shares (1 derivative) of Quanterix Corp (QTRX) Transaction Date: Aug 19, 2026 | Filing ID: 000005

Full text

News bot Aug. 20, 2026, 9 p.m.
🔍 Elliott Jeffrey Thomas (Executive)

Company: Quanterix Corp (QTRX)

Report Date: 2026-08-19
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 3,955
- Total shares sold: 3,955
Detailed Transactions and Holdings:
- Acquired 3,955 shares of Common Stock (Direct)
  Date: 2026-08-19 | Code: M | equity_swap_involved: false | shares_owned_after: 15,345.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 3,955 shares of Restricted Stock Unit (Derivative)
  Date: 2026-08-19 | Code: M | equity_swap_involved: false | shares_owned_after: 4,075.00 | transaction_form_type: 4 | Footnotes: F2, F2
Footnotes:
- F1: Restricted stock units convert into common stock on a one-for-one basis.
- F2: On August 19, 2024, the reporting person was granted 11,985 restricted stock units, vesting 33%, 33%, and 34% on the first, second, and third anniversaries of the grant date, respectively.